Alzheimer's Disease Trial, Recruiting NCT00064870 Sponsor: Indiana University Condition: Alzheimer's Disease
Back to Alzheimers Disease

Alzheimer's Disease Trial, Recruiting

NCT00064870
Recruiting Not Applicable

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • The family must have at least two living members who have been diagnosed with Alzheimer's disease or another form of dementia (diagnosis can be at any age)
  • Biological samples must be available from family members, which can be fresh blood, specially preserved blood cells grown in a lab (called immortalized lymphoblastic cell lines), or 3–5 grams of frozen brain tissue from the outer part of the brain (fixed/preserved tissue samples are not accepted)

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • Families who do not meet the requirements listed above
  • Families whose members were already included in a previous government-funded study called the National Institute of Mental Health Alzheimer's Disease Genetics Sib Pair collection

Please note: This study does not include genetic counselling. Because no personal identifying information (such as names or dates of birth) is attached to the samples, individual test results are not made available to participants or their family members.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 13 August 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Tatiana M. Foroud, PhD, National Centralized Repository for Alzheimer's Disease and Related Dementias (NCRAD), Indiana University

Phone: 1-800-526-2839

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
1 June 2002
Est. completion
1 July 2026

This date has passed while the registry still lists the trial as open to participants. Sponsors often update a trial's status without revising its projected end date, so it may well still be recruiting — but the record is out of date in at least one respect. Check with the study contact before relying on either.

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Distribute biological specimens to qualified investigators for use in their research studies.

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 13 August 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov